Bringing the fundamentals into focus…
Back to CytomX Therapeutics, Inc.
How CytomX Therapeutics, Inc. stacks up
CTMX · against 399 other Healthcare companies of similar size
Growth
3/ 100
Near the bottom of its peers.
Ranked #382 of 400 · scores higher than 3% of peers
Bars: peers in each 10-point band of the growth score56 peers with a growth score of 0–9, including CTMX · Click a bar to see the companies
Why growth scores 3?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 98% of peers. Revenue growth: -87.0% vs peer median 6.1%
- slower revenue growth over three years: weaker than 97% of peers. 3-year revenue growth: -38.7% vs peer median 5.8%
- Earnings per share turned from a profit to a loss. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = CTMX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CTMX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 413 reported | -87.0% | 3.0% | 1% | 33% | |
| Earnings per share growthHigher is better · 203 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 392 reported | -38.7% | 3.5% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around CTMX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 5 | 3.9B HKD (≈$493M) | 98 | 66 | |
| 382 | 2.3B CNY (≈$322M) | 3 | 10 | |
| 382 | 3.4B CNY (≈$469M) | 3 | 42 | |
| 382 | 2.1B CNY (≈$291M) | 3 | 9 | |
| 382 | 271M USD | 3 | 14 | |
| 382 | 475M USD | 3 | 22 | |
| 382 | 888M USD | 3 | 25 | |
| 389 | 3.5B HKD (≈$451M) | 2 | 51 | |
| 389 | 5.1B CNY (≈$709M) | 2 | 12 | |
| 389 | 4.0B CNY (≈$563M) | 2 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score